Positive fecal immunochemical test results are associated with non-colorectal cancer mortality
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Studies have reported an association between fecal occult blood and increased all-cause, non-colorectal cancer (CRC) as well as CRC mortality. This study aimed to determine whether positive fecal immunochemistry test (FIT) results are associated with death from various causes in the South Korean population. Methods: Using the Korean National Cancer Screening Program database, we collected data on patients who underwent FIT between 2009 and 2011. Results: Of the 5,932,544 participants, 380,789 (6.4%) had positive FIT results. FIT-positive participants had a higher mortality rate than FIT-negative participants from CRC (1.33 and 0.21 per 1,000 person-years, p < 0.001, respectively) and non- CRC causes (10.40 and 7.50 per 1,000 person-years, p < 0.001, respectively). Despite adjusting for age, sex, smoking status, alcohol consumption habits, body mass index, comorbidity, and aspirin use, FIT positivity was associated with an increased risk of dying from all non-CRC causes (adjusted hazard ratio [aHR], 1.17; 95% confidence interval [CI], 1.15 to 1.18) and CRC (aHR, 5.61; 95% CI, 5.40 to 5.84). Additionally, FIT positivity was significantly associated with increased mortality from circulatory disease (aHR, 1.14; 95% CI, 1.11 to 1.17), respiratory disease (aHR, 1.14; 95% CI, 1.09 to 1.19), digestive disease (aHR, 1.57; 95% CI, 1.48 to 1.66), neuropsychological disease (aHR, 1.08; 95% CI, 1.01 to 1.16), blood and endocrine diseases (aHR, 1.10; 95% CI, 1.04 to 1.17), and external factors (aHR, 1.16; 95% CI, 1.11 to 1.20). Conclusions: Positive FIT results are associated with an increased risk of mortality from CRC and various other chronic diseases, suggesting that it could be a predictor of mortality independent of its association with CRC.
Abstract
Background/Aims: Studies have reported an association between fecal occult blood and increased all-cause, non-colorectal cancer (CRC) as well as CRC mortality. This study aimed to determine whether positive fecal immunochemistry test (FIT) results are associated with death from various causes in the South Korean population. Methods: Using the Korean National Cancer Screening Program database, we collected data on patients who underwent FIT between 2009 and 2011. Results: Of the 5,932,544 participants, 380,789 (6.4%) had positive FIT results. FIT-positive participants had a higher mortality rate than FIT-negative participants from CRC (1.33 and 0.21 per 1,000 person-years, p < 0.001, respectively) and non- CRC causes (10.40 and 7.50 per 1,000 person-years, p < 0.001, respectively). Despite adjusting for age, sex, smoking status, alcohol consumption habits, body mass index, comorbidity, and aspirin use, FIT positivity was associated with an increased risk of dying from all non-CRC causes (adjusted hazard ratio [aHR], 1.17; 95% confidence interval [CI], 1.15 to 1.18) and CRC (aHR, 5.61; 95% CI, 5.40 to 5.84). Additionally, FIT positivity was significantly associated with increased mortality from circulatory disease (aHR, 1.14; 95% CI, 1.11 to 1.17), respiratory disease (aHR, 1.14; 95% CI, 1.09 to 1.19), digestive disease (aHR, 1.57; 95% CI, 1.48 to 1.66), neuropsychological disease (aHR, 1.08; 95% CI, 1.01 to 1.16), blood and endocrine diseases (aHR, 1.10; 95% CI, 1.04 to 1.17), and external factors (aHR, 1.16; 95% CI, 1.11 to 1.20). Conclusions: Positive FIT results are associated with an increased risk of mortality from CRC and various other chronic diseases, suggesting that it could be a predictor of mortality independent of its association with CRC.
참고문헌 (37)
- Robertson DJ, "Recommendations on fecal immunochemical testing to screen for colorectal neoplasia : a Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer", Gastroenterology, 152, pp.1217~1237 (2017)
- Kronborg O, "Randomised study of screening for colorectal cancer with faecal-occult-blood test", Lancet, 348, pp.1467~1471 (1996)
- Hardcastle JD, "Randomised controlled trial of faecal-occult-blood screening for colorectal cancer", Lancet, 348, pp.1472~1477 (1996)
- Rex DK, "Colorectal cancer screening : recommendations for physicians and patients from the U. S. Multi-Society Task Force on Colorectal Cancer", Am J Gastroenterol, 112, pp.1016~1030 (2017)
- Park DI, "Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening", Am J Gastroenterol, 105, pp.2017~2025 (2010)
- Parra-Blanco A, "Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening", J Gastroenterol, 45, pp.703~712 (2010)
- Brenner H, "Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy", Eur J Cancer, 49, pp.3049~3054 (2013)
- Allison JE, "A comparison of fecal occult-blood tests for colorectal-cancer screening", N Engl J Med, 334, pp.155~159 (1996)
- Hassan C, "Meta-analysis : adherence to colorectal cancer screening and the detection rate for advanced neoplasia, according to the type of screening test", Aliment Pharmacol Ther, 36, pp.929~940 (2012)
- Libby G, "Occult blood in faeces is associated with all-cause and non-colorectal cancer mortality", Gut, 67, pp.2116~2123 (2018)
- Charlson ME, "A new method of classifying prognostic comorbidity in longitudinal studies : development and validation", J Chronic Dis, 40, pp.373~383 (1987)
- "Cause of death statistics:statistical information report 2019" (2019)[URL]
- Whynes DK, "Analysis of deaths occurring within the Nottingham trial of faecal occult blood screening for colorectal cancer", Gut, 59, pp.1088~1093 (2010)
- Chen LS, "Impact of faecal haemoglobin concentration on colorectal cancer mortality and allcause death", BMJ Open, 3, pp.e003740~ (2013)
- Barrows GH, "Immunochemical detection of human blood in feces", Am J Clin Pathol, 69, pp.342~346 (1978)
- Kim NH, "Does low threshold value use improve proximal neoplasia detection by fecal immunochemical test?", Dig Dis Sci, 61, pp.2685~2693 (2016)
- Feldman C, "Pneumonia as a systemic illness", Curr Opin Pulm Med, 24, pp.237~243 (2018)
- Piotrowski I, "Interplay between inflammation and cancer", Rep Pract Oncol Radiother, 25, pp.422~427 (2020)
- Menini S, "The inflammasome in chronic complications of diabetes and related metabolic disorders", Cells, 9, pp.1812~ (2020)
- Reddy P, "Metabolic syndrome is an inflammatory disorder : a conspiracy between adipose tissue and phagocytes", Clin Chim Acta, 496, pp.35~44 (2019)
- Arnold N, "Atherosclerosis as an inflammatory disease : pathophysiology, clinical relevance and therapeutic implications", Dtsch Med Wochenschr, 144, pp.315~321 (2019)
- Tanaka M, "Exploring the etiological links behind neurodegenerative diseases : inflammatory cytokines and bioactive kynurenines", Int J Mol Sci, 21, pp.2431~ (2020)
- Yamamoto T, "Endoscopic score vs. fecal biomarkers for predicting relapse in patients with ulcerative colitis after clinical remission and mucosal healing", Clin Transl Gastroenterol, 9, pp.136~ (2018)
- Mine S, "Correlation of fecal markers with magnifying endoscopic stratification in patients with ulcerative colitis who are in clinical remission", Digestion, 97, pp.82~89 (2018)
- Tian R, "C-reactive protein for predicting cardiovascular and all-cause mortality in type 2 diabetic patients : a meta-analysis", Cytokine, 117, pp.59~64 (2019)
- Proctor MJ, "Systemic inflammation predicts all-cause mortality : a glasgow inflammation outcome study", PLoS One, 10, pp.e0116206~ (2015)
- Ogunrinola GA, "The human microbiome and its impacts on health", Int J Microbiol, 2020, pp.8045646~ (2020)
- Panida Sittipo, "Intestinal microbiota and the immune system in metabolic diseases", The Journal of Microbiology, 56(3), pp.154~162 (2018), 한국미생물학회[DOI]
- Anselmi G, "Gut microbiota and cardiovascular diseases : a critical review", Cardiol Rev, 29, pp.195~204 (2021)
- Sekirov I, "Gut microbiota in health and disease", Physiol Rev, 90, pp.859~904 (2010)
- Cox AJ, "Obesity, inflammation, and the gut microbiota", Lancet Diabetes Endocrinol, 3, pp.207~215 (2015)
- Redondo-Useros N, "Microbiota and lifestyle : a special focus on diet", Nutrients, 12, pp.1776~ (2020)
- Rom O, "Cigarette smoking and inflammation revisited", Respir Physiol Neurobiol, 187, pp.5~10 (2013)
- Nimmo MA, "The effect of physical activity on mediators of inflammation", Diabetes Obes Metab, 15(Suppl 3), pp.51~60 (2013)
- Oines M, "Epidemiology and risk factors of colorectal polyps", Best Pract Res Clin Gastroenterol, 31, pp.419~424 (2017)
- Jung YS, "Risk factors for colorectal neoplasia in persons aged 30 to 39 years and 40 to 49 years", Gastrointest Endosc, 81, pp.637~645 (2015)
- Martin CS Wong, "Prevalence and risk factors of colorectal cancer in Asia", Intestinal research, 17(3), pp.317~329 (2019), 대한장연구학회[DOI]